November 18, 2020 Among NGOs attending the SCCR 40, there are clear opposite views of what should be done by the SCCR right now. The rightholders (collective societies and producers) say things are fine, they just need more licensing opportunities.… Continue Reading
This is the statement the United States of America delivered on behalf of the US government at the WIPO General Assembly, on the work program for the Standing Committee on Copyright and Related Rights (SCCR) on Tuesday, 5 October 2021.… Continue Reading
On Tuesday, 5 October 2021, Knowledge Ecology International delivered the following statement on Agenda item 13, Report on the Standing Committee on Copyright and Related Rights (SCCR). Statement of Knowledge Ecology International – Agenda Item 13: Report on the Standing… Continue Reading
On Tuesday, 5 October 2021, Knowledge Ecology International delivered the following opening statement at the 2021 WIPO General Assembly. General Statement of Knowledge Ecology International – WIPO General Assembly 5 October 2021 The COVID pandemic illustrates flaws in the intellectual… Continue Reading
On Wednesday, 30 June 2021, Knowledge Ecology International delivered the following statement on copyright in the digital environment at WIPO’s 41st session of the Standing Committee on Copyright and Related Rights . SCCR 41 – KEI statement on copyright in… Continue Reading
On Tuesday, 29 June 2021, Knowledge Ecology International (KEI) delivered the following statement on copyright limitations and exceptions. SCCR 41 – KEI statement on limitations and exceptions Limitations and exceptions are important for individuals and society, particularly with regards to… Continue Reading
On Monday, 28 June 2021, Knowledge Ecology International (KEI) delivered the following statement on the proposed WIPO broadcasting treaty. SCCR 41 – KEI statement on broadcasting New measures to address signal theft are one thing. But granting durable post-fixation rights… Continue Reading
Ahead of the 74th World Health Assembly, Health Action International, Knowledge Ecology International, and Medicines Law & Policy will be co-hosting a discussion with a high-level panel on what a pandemic response treaty should say about the sharing of rights… Continue Reading
On March 11th 2021, Biolyse Pharma (“Biolyse”) issued a statement publicly indicating their capacity to manufacture a COVID-19 vaccine and their intent to apply for a compulsory license in Canada. Biolyse is a Canadian manufacturer of cancer drugs based out… Continue Reading
The contract awarding Sanofi Pasteur (“Sanofi”) 1.8 billion U.S. taxpayers’ dollars for the development and manufacture of a COVID-19 vaccine was posted in the Department of Health and Human Services (HHS) Electronic Reading Room on November 30, 2020. Overall, the… Continue Reading